Aptabio Therapeutics Inc (XKRX:293780)
â‚© 8350 350 (4.38%) Market Cap: 186.20 Bil Enterprise Value: 153.59 Bil PE Ratio: 0 PB Ratio: 3.72 GF Score: 52/100

Aptabio Therapeutics Inc (XKRX:293780) Transcripts

    • 1